VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Cash flow

755 Followers

VistaGen Therapeutics Cash Flow

VTGN's free cash flow for Q4 2024 was $-7.20M. For the 2024 fiscal year, VTGN's free cash flow was decreased by $24.43M and operating cash flow was $-7.20M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
$ -25.81M$ -25.81M$ -49.72M$ -46.26M$ -12.07M$ -15.76M
Investing Cash Flow
$ -61.00K$ -61.00K$ -740.30K$ -200.40K$ -275.40K$ 0.00
Financing Cash Flow
$ 128.40M$ 128.40M$ -1.04M$ 6.09M$ 114.10M$ 4.01M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 292.96M$ 119.17M$ 16.64M$ 62.73M$ 101.62M$ 1.36M
Income Tax Paid Supplemental Data
---$ 3.40K$ 2.60K$ 2.60K
Interest Paid Supplemental Data
---$ 300.00$ 13.30K$ 14.80K
Issuance Of Capital Stock
$ 93.45M$ 93.45M--$ 15.80M$ 3.60M
Issuance Of Debt
$ -985.00K$ -985.00K$ -1.04M$ -3.00K$ -382.00K$ 0.00
Repayment Of Debt
$ -201.60K$ -985.00K$ -1.04M$ -3.00K$ -606.40K$ -296.60K
Free Cash Flow
$ -19.62M$ -25.81M$ -50.24M$ -46.26M$ -12.35M$ -15.76M
Domestic Sales
------
Foreign Sales
------
Currency in USD

VistaGen Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis